CVS Health Co. (NYSE:CVS) Shares Sold by Capital Advisors Ltd. LLC

Capital Advisors Ltd. LLC trimmed its holdings in CVS Health Co. (NYSE:CVS) by 30.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 687 shares of the pharmacy operator’s stock after selling 299 shares during the quarter. Capital Advisors Ltd. LLC’s holdings in CVS Health were worth $31,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health during the third quarter valued at about $25,000. Ridgewood Investments LLC lifted its stake in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC purchased a new stake in CVS Health during the fourth quarter valued at about $28,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health during the third quarter valued at about $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter valued at about $32,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have commented on CVS shares. Truist Financial upped their price objective on shares of CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Wolfe Research upped their target price on CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a report on Tuesday, February 11th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. Royal Bank of Canada dropped their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Finally, Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $70.00.

Insider Activity

In other CVS Health news, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction dated Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.24% of the stock is owned by company insiders.

CVS Health Trading Down 0.8 %

Shares of CVS stock opened at $62.95 on Tuesday. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The business’s 50 day moving average is $52.72 and its two-hundred day moving average is $56.25. The company has a market cap of $79.37 billion, a PE ratio of 17.20, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Equities analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.23%. CVS Health’s dividend payout ratio is 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.